German-developed cancer vaccine expected by 2030 : compareme

The Turkish-German BioNTech founders Uğur Şahin and Özlem Türeci have announced that a vaccine to target cancer cells could be ready for patients by 2030.

Related Keywords

Germany , Turkey , German , , Uğur Şahin , Özlem Türeci , Biontech Cancer Vaccine , Cancer Cures , Cancer Treatment Advancements , Cancer Vaccine Germany , Vaccine Advances , Cancer Treatment Germany , Bowel Cancer Treatment , Mrna Molecule , Vaccine Research Germany , Cancer Cells Vaccine , 2030 Cancer Cure ,